Yukihiko Hiroshima

6PUBLICATIONS
23CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2026
Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline MSH6 Variant: A Case Report.

|Jul 10, 2026
Real-World Genomic Characteristics and Prognostic Association in Advanced Papillary Thyroid Carcinoma.

|Jun 26, 2026
A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

|Jun 02, 2026
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

|Aug 28, 2025
Overexpression of Nuclear Factor of Activated T-cells (NFAT) Transcription Factors Drives Chemoresistance and Poor Outcomes in Pancreatic Cancer.

Yuto Kamioka, Yukihiko Hiroshima, Wataru Kawase

|Nov 27, 2024
Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study.

Ann Sato, Eri Haneda, Yukihiko Hiroshima

Pageof 1

Frequent Collaborators

2 joint publications

Hiroto Narimatsu

1 joint publications

Ann Sato

1 joint publications

Eri Haneda

1 joint publications

Shuji Murakami